Section 63 Adulteration of medicinal products.C2C1
United Kingdom
No person shall—
add any substance to, or abstract any substance from, a medicinal product so as to affect injuriously the composition of the product, with intent that the product shall be sold or supplied in that state, or
sell or supply, or offer or expose for sale or supply, or have in his possession for the purpose of sale or supply, any medicinal product whose composition has been injuriously affected by the addition or abstraction of any substance.
Annotations
Modifications
- C1
S. 63 applied (1.1.1995) by S.I 1994/3142, reg. 18(2)
- C2
Ss. 63–65 extended by S.I. 1984/187, art. 2
Notes on Part III
Modifications
- C1
Part III (ss.51-68) modified (1.1.1995) by S.I. 1994/3144, reg. 9(9)
- C2
Pt. III amendment to earlier affecting provision SI 1994/3144 reg. 9 (30.10.2005) by Medicines (Marketing Authorisations Etc.) Amendment Regulations 2005 (S.I. 2005/2759), regs. 1(a), 2(12)